Related Experiment Video

Updated: May 20, 2025

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

11.4K

Neoantigen Vaccines in Cancer Prevention

Abel Martel-Martel1, Krishna M Sinha, Eduardo Vilar

  • 1Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX.

Cancer Journal (Sudbury, Mass.)
|March 24, 2025
PubMed

Insights

Neoantigen-based vaccines offer a novel cancer prevention strategy by targeting tumor-specific mutations. These vaccines can be administered to high-risk individuals to activate immunity and potentially prevent cancer development.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Cancer immunotherapy has advanced significantly, with neoantigen vaccines emerging as a key strategy.
  • Neoantigens, derived from somatic mutations, allow for tumor-specific targeting, minimizing autoimmune risks.
  • Standardized, off-the-shelf neoantigen vaccines present a scalable approach for cancer prevention in high-risk groups.

Purpose of the Study:

  • To review the biological mechanisms, clinical development, and future potential of neoantigen-based vaccines for cancer prevention.
  • To highlight the role of neoantigen vaccines in intercepting cancer development through early immune activation.
  • To emphasize the revolutionary potential of neoantigen vaccines in cancer risk-reduction strategies.

Main Methods:

  • Review of current literature on cancer immunotherapy and neoantigen vaccine development.
  • Analysis of advances in next-generation sequencing and computational biology for neoantigen prediction.
  • Examination of vaccine delivery platforms and combination strategies with other therapies.

Main Results:

  • Neoantigen vaccines enable precise targeting of cancer cells, enhancing immune responses and reducing side effects.
  • Technological advancements improve neoantigen prediction accuracy and vaccine efficacy.
  • Combination therapies involving neoantigen vaccines show synergistic potential for boosting cellular immunity.

Conclusions:

  • Neoantigen-based vaccines represent a promising frontier in cancer prevention, particularly for genetically predisposed populations.
  • Early immune activation via neoantigen vaccines can potentially intercept cancer development before malignancy.
  • Further research and clinical development are crucial to realize the full potential of neoantigen vaccines in revolutionizing cancer prevention.

More Related Videos

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.4K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

1.6K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
310
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.3K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K